These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 15287722)

  • 1. Catalysis and function of the p38 alpha.MK2a signaling complex.
    Lukas SM; Kroe RR; Wildeson J; Peet GW; Frego L; Davidson W; Ingraham RH; Pargellis CA; Labadia ME; Werneburg BG
    Biochemistry; 2004 Aug; 43(31):9950-60. PubMed ID: 15287722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and characterization of a substrate selective p38alpha inhibitor.
    Davidson W; Frego L; Peet GW; Kroe RR; Labadia ME; Lukas SM; Snow RJ; Jakes S; Grygon CA; Pargellis C; Werneburg BG
    Biochemistry; 2004 Sep; 43(37):11658-71. PubMed ID: 15362850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p38 mitogen-activated protein kinase plays a key role in regulating MAPKAPK2 expression.
    Sudo T; Kawai K; Matsuzaki H; Osada H
    Biochem Biophys Res Commun; 2005 Nov; 337(2):415-21. PubMed ID: 16198317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogen-activated protein kinase activated protein kinase 2 (MK2) participates in p38 MAPK regulated control of oligodendrocyte differentiation.
    Haines JD; Fang J; Mushynski WE; Almazan G
    Glia; 2010 Aug; 58(11):1384-93. PubMed ID: 20607863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermal denaturation: a method to rank slow binding, high-affinity P38alpha MAP kinase inhibitors.
    Kroe RR; Regan J; Proto A; Peet GW; Roy T; Landro LD; Fuschetto NG; Pargellis CA; Ingraham RH
    J Med Chem; 2003 Oct; 46(22):4669-75. PubMed ID: 14561086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analysis of an MK2-inhibitor complex: insight into the regulation of the secondary structure of the Gly-rich loop by TEI-I01800.
    Fujino A; Fukushima K; Namiki N; Kosugi T; Takimoto-Kamimura M
    Acta Crystallogr D Biol Crystallogr; 2010 Jan; 66(Pt 1):80-7. PubMed ID: 20057052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the molecular basis of MK2-p38α signaling complex assembly: insights into protein-protein interaction by molecular dynamics and free energy studies.
    Yang Y; Liu H; Yao X
    Mol Biosyst; 2012 Aug; 8(8):2106-18. PubMed ID: 22648002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of a stable MK2-EGFP cell line and subsequent development of a high-content imaging assay on the Cellomics ArrayScan platform to screen for p38 mitogen-activated protein kinase inhibitors.
    Williams RG; Kandasamy R; Nickischer D; Trask OJ; Laethem C; Johnston PA; Johnston PA
    Methods Enzymol; 2006; 414():364-89. PubMed ID: 17110203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of ERK1/2 and p38(MAPK) by components of the Rho signaling pathway during sphingosine-1-phosphate-induced smooth muscle cell migration.
    Galaria II; Fegley AJ; Nicholl SM; Roztocil E; Davies MG
    J Surg Res; 2004 Dec; 122(2):173-9. PubMed ID: 15555614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-resolved Forster resonance energy transfer assays for the binding of nucleotide and protein substrates to p38alpha protein kinase.
    Zhang WX; Wang R; Wisniewski D; Marcy AI; LoGrasso P; Lisnock JM; Cummings RT; Thompson JE
    Anal Biochem; 2005 Aug; 343(1):76-83. PubMed ID: 15979553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two additive mechanisms impair the differentiation of 'substrate-selective' p38 inhibitors from classical p38 inhibitors in vitro.
    Hendriks BS; Seidl KM; Chabot JR
    BMC Syst Biol; 2010 Mar; 4():23. PubMed ID: 20230629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of PTP-SL/PTPBR7 catalytic domain: implications for MAP kinase regulation.
    Szedlacsek SE; Aricescu AR; Fulga TA; Renault L; Scheidig AJ
    J Mol Biol; 2001 Aug; 311(3):557-68. PubMed ID: 11493009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling for kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation.
    Nickischer D; Laethem C; Trask OJ; Williams RG; Kandasamy R; Johnston PA; Johnston PA
    Methods Enzymol; 2006; 414():389-418. PubMed ID: 17110204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actinobacillus actinomycetemcomitans lipopolysaccharide induces interleukin-6 expression through multiple mitogen-activated protein kinase pathways in periodontal ligament fibroblasts.
    Patil C; Rossa C; Kirkwood KL
    Oral Microbiol Immunol; 2006 Dec; 21(6):392-8. PubMed ID: 17064398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of construct design on MAPKAP kinase-2 activity, thermodynamic stability and ligand-binding affinity.
    Kervinen J; Ma H; Bayoumy S; Schubert C; Milligan C; Lewandowski F; Moriarty K; Desjarlais RL; Ramachandren K; Wang H; Harris CA; Grasberger B; Todd M; Springer BA; Deckman I
    Arch Biochem Biophys; 2006 May; 449(1-2):47-56. PubMed ID: 16620770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear protein NP60 regulates p38 MAPK activity.
    Fu J; Yang Z; Wei J; Han J; Gu J
    J Cell Sci; 2006 Jan; 119(Pt 1):115-23. PubMed ID: 16352664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structures of p38alpha active mutants reveal conformational changes in L16 loop that induce autophosphorylation and activation.
    Diskin R; Lebendiker M; Engelberg D; Livnah O
    J Mol Biol; 2007 Jan; 365(1):66-76. PubMed ID: 17059827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
    Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
    J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel lipid binding site formed by the MAP kinase insert in p38 alpha.
    Diskin R; Engelberg D; Livnah O
    J Mol Biol; 2008 Jan; 375(1):70-9. PubMed ID: 17999933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay development and case history of a 32K-biased library high-content MK2-EGFP translocation screen to identify p38 mitogen-activated protein kinase inhibitors on the ArrayScan 3.1 imaging platform.
    Trask OJ; Baker A; Williams RG; Nickischer D; Kandasamy R; Laethem C; Johnston PA; Johnston PA
    Methods Enzymol; 2006; 414():419-39. PubMed ID: 17110205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.